Kaizen Drugs Private Limited - Company Profile

It is a chemicals and materials private limited company based in Chandigarh, Chandigarh, India, established in 1995.
1995 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Kaizen Drugs Private Limited

Kaizen Drugs Private Limited, a active private limited company, was established on 08 February 1995 in Chandigarh, Chandigarh, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24231CH1995PTC015776. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.42 M.

Formerly known as Talson Drugs `Private Limited, Talson Drugs Private Limited. It upholds a compliant status. Employing 12 professional, Its leadership includes Shivali Khanduja (Whole-Time Director), Vivek Khanduja (Managing Director). Past directors included Krishan Lal Khanduja, Shivali Khanduja, Ranjana Khanduja. It holds ₹7.54 Cr open charges and ₹7.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No 117/2, Old Mansa Devi Road,Manimajra, Chandigarh, Chandigarh, 160101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231CH1995PTC015776

  • Registration Number

    015776

  • Incorporation Date

    08 February 1995

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹2.42 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 2.42 M
  • Company Age 31 Year, 12 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.54 Cr
  • Satisfied Charges ₹ 7.10 Cr
  • Revenue Growth **** 42.89%
  • Profit Growth **** 43.94%
  • Ebitda **** 37.74%
  • Net Worth 6.04%
  • Total Assets **** 5.00%
Company report

Kaizen Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kaizen Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kaizen Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Shivali Khanduja Whole-Time Director 11 May 2010 Current
Vivek Khanduja Managing Director 15 Sep 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Nov 2017 Past
Pramod Abcsdd Director 01 Apr 2015 Past
Pramod Abcsdd Director 05 Apr 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kaizen Drugs.

Kaizen Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.89% increase. The company also saw a substantial improvement in profitability, with a 43.94% increase in profit. The company's net worth moved up by a moderate rise of 6.04%.

Kaizen Drugs revenue growth over time
Kaizen Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.89%
*******
*******
*******
*******
Revenue from Operations
*******
 42.99%
*******
*******
*******
*******
Total Assets
*******
 5.00%
*******
*******
*******
*******
Profit or Loss
*******
 43.94%
*******
*******
*******
*******
Net Worth
*******
 6.04%
*******
*******
*******
*******
EBITDA
*******
 37.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kaizen Drugs?

Unlock access to Kaizen Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹75,379,000.00

Satisfied Charges

₹71,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 6.00 Cr
  • Sidbi : 1.54 Cr
Latest Charge Details
Date Lender Amount Status
29 Oct 2024 Sidbi ₹2.00 M Open
26 Jul 2024 Others ₹3.00 Cr Open
30 Mar 2024 Others ₹3.00 Cr Open
22 Nov 2023 Sidbi ₹1.81 M Open
02 Jan 2023 Sidbi ₹4.86 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Kaizen Drugs?

Kaizen Drugs has a workforce of 12 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kaizen Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaizen Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kaizen Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Kaizen Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Kaizen Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was documented.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 2.00 M with Charge ID 100994995 was registered on 29 Oct 2024. was documented.

  • Charges

    A charge with Others amounted to Rs. 30.00 M with Charge ID 100974999 was registered on 26 Jul 2024. was recorded as a recent event.

  • Charges

    A charge registered on 22 Jul 2019 via Charge ID 100277371 with Others was fully satisfied on 07 Jun 2024. was recorded as a recent event.

  • Charges

    A charge registered on 13 Jan 2012 via Charge ID 10334770 with Oriental Bank Of Commerce was fully satisfied on 07 Jun 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kaizen Drugs Private Limited?

The CIN of Kaizen Drugs Private Limited is U24231CH1995PTC015776.

Where is Kaizen Drugs Private Limited headquartered?

Kaizen Drugs Private Limited is headquartered at Shop No 117/2, Old Mansa Devi Road,Manimajra, Chandigarh, Chandigarh, 160101.

When was Kaizen Drugs Private Limited incorporated?

Kaizen Drugs Private Limited was incorporated on 08 February 1995.

Who are the current directors of Kaizen Drugs Private Limited?

The current directors of Kaizen Drugs Private Limited are

What is the primary industry of Kaizen Drugs Private Limited?

The primary industry of Kaizen Drugs Private Limited is Trade.

Is Kaizen Drugs Private Limited a listed company?

Kaizen Drugs Private Limited is unlisted.

What is the capital structure of Kaizen Drugs Private Limited?

The authorized capital of Kaizen Drugs Private Limited is ₹3.00 M, and the paid-up capital is ₹2.42 M.

What is the compliance status of Kaizen Drugs Private Limited?

The compliance status of Kaizen Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available